Kiromic Biopharma, Inc. Note Agreements
25 Contracts & Agreements
- 25% Senior Secured Convertible Promissory Note (Filed With SEC on June 27, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on June 7, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on May 6, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on April 5, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on March 11, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on February 14, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on January 11, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on December 15, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on November 6, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on October 2, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on August 29, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on July 27, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on June 27, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on May 30, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on April 28, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on March 31, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on February 27, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on January 26, 2023)
- Form of Note Purchase Agreement (Filed With SEC on January 26, 2023)
- Form of the Amended and Restated 25% Senior Secured Convertible Promissory Note (Filed With SEC on December 16, 2022)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on October 27, 2022)
- Form of the Subordinated Convertible Promissory Note (Filed With SEC on October 14, 2022)
- Form of 7% Convertible Promissory Note issued by Kiromic BioPharma, Inc. to certain investors (Filed With SEC on May 11, 2020)
- Form of 17% Convertible Promissory Note issued by Kiromic BioPharma, Inc. to certain investors (Filed With SEC on May 11, 2020)
- Convertible Promissory Note issued by Kiromic BioPharma, Inc. to Prevail Partners on May 30, 2019 (Filed With SEC on May 11, 2020)
